OncoPep
Blood & Organ Banks · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
520 Boston St, North Andover, Massachuse...Phone Number
(978) 837-1129Website
www.oncopep.comRevenue
<$5 MillionIndustry
ZI Rank: 2
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
3
2
2
6
2
2
About OncoPep
OncoPep, Inc., located in North Andover, Massachusetts, is a biotech company that specializes in developing targeted immunotherapeutics against cancer. The technology, which OncoPep has exclusively licensed, employs a unique combination of proprietary peptides to form a therapeutic cancer vaccine. Vaccines developed from this technology are designed to stimulate the patient's immune system to attack cancer through an optimized combination of disease-specific peptides and adjuvants (substances that stimulate the immune system).Explore more
OncoPep Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is OncoPep your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on OncoPep recently announced quarterly report
OncoPep, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once OncoPep has new funding data
Click to see if OncoPep had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Check out if OncoPep is spiking on competitors!
Check if OncoPep has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at OncoPep
Product Launch: Get notified when OncoPep launches new products
Recommended Actions
Find VP level buyers at OncoPep
Find 2 more new buyers
Compare Similar Companies to OncoPep
Compare insights from companies similar to OncoPep, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
OncoPep is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
OncoPep is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about OncoPep.
OncoPep financials insights
Gather financial insights about OncoPep, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2011
Angel/Seed
$4.5M
2012
Series A
$2.5M
2014
Private Equity
$3.5M
Series B
$6.9M
2021
Series D
$11M
OncoPep Tech Stack
A closer look at the technologies used by OncoPep
See more technologies
OncoPep News & Media
OncoPep to Attend Bio US 2022 to Further KOSDAQ IPO and Korea-USA Industry Relationships
CAMBRIDGE, Mass. , June 14, 2022 /PRNewswire/ -- OncoPep, Inc. is proud to be a participant at this year's BIO International Convention 2022 conference June 13-16 in San Diego CA. The company will be sending members of its executive team including CEO Arthur Becker and CFO Sanghyuck Nam....Dr. Victor Moyo, MBChB, Joins OncoPep as Chief Medical Officer
CAMBRIDGE, Mass., May 17, 2022 /PRNewswire/ -- OncoPep, Inc. has named Dr. Victor Moyo Chief Medical Officer effective May 9th. As CMO, Moyo will provide strategic clinical leadership to ensure delivery of OncoPep's efforts to develop transformative immunotherapeutics. Moyo has over 16...OncoPep Completes $11 Million Series D Financing to Continue Clinical Trials and Advance Pipeline Development
CAMBRIDGE, Mass., Dec. 9, 2021 /PRNewswire/ -- OncoPep, Inc., a developer of transformative immunotherapeutics, announced $11 million in Series D funding. The Series D was led by Tera Science and Kukje Pharma with participation from SX Company and CrystalBioScience. The Series D funding...Carl Novina, MD, PhD, Joins OncoPep Scientific Advisory Board
CAMBRIDGE, Mass., Nov. 9, 2021 /PRNewswire/ -- OncoPep, Inc. today announced it is expanding its Scientific Advisory Board with the addition of Carl Novina, MD, PhD. As the leader and founder of the Dana-Farber/Harvard Cancer Institute's Novina Laboratory, Dr. Carl Novina and his team...
Read more news
Top Blood & Organ Banks Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding OncoPep
Sign Up For FreeTo access detailed company insights
OncoPep, Inc., located in North Andover, Massachusetts, is a biotech company that specializes in developing targeted immunotherapeutics against cancer. The technology, which OncoPep has exclusively licensed, employs a unique combination of proprietary peptides to form a therapeutic cancer vaccine. Vaccines developed from this technology are designe... Read More
